The impact that [D-glucose] had on GPER1-dependent tamoxifen action in breast cancer cells was demonstrated by measuring the accumulation of IGFBP-1 expression in tamoxifen-treated breast cancer cells in the presence of increasing [D-glucose]. The gene discussed is IGFBP1; the disease is breast carcinoma.